Mark C. Walters

10.7k total citations · 1 hit paper
160 papers, 5.4k citations indexed

About

Mark C. Walters is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Mark C. Walters has authored 160 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Genetics, 74 papers in Hematology and 62 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Mark C. Walters's work include Hemoglobinopathies and Related Disorders (105 papers), Prenatal Screening and Diagnostics (57 papers) and Hematopoietic Stem Cell Transplantation (44 papers). Mark C. Walters is often cited by papers focused on Hemoglobinopathies and Related Disorders (105 papers), Prenatal Screening and Diagnostics (57 papers) and Hematopoietic Stem Cell Transplantation (44 papers). Mark C. Walters collaborates with scholars based in United States, France and Germany. Mark C. Walters's co-authors include David I. K. Martin, Mark Groudine, Keith M. Sullivan, Wendy Magis, Rainer Storb, Steven Fiering, Mary Eapen, Monica Bhatia, Elliott Vichinsky and Françoise Bernaudin and has published in prestigious journals such as New England Journal of Medicine, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Mark C. Walters

152 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells

2016 342 citations Mark A. DeWitt, Wendy Magis et al. profile →

Peers

Countries citing papers authored by Mark C. Walters

Since Specialization

Citations

This map shows the geographic impact of Mark C. Walters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark C. Walters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark C. Walters more than expected).

Fields of papers citing papers by Mark C. Walters

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark C. Walters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark C. Walters. The network helps show where Mark C. Walters may publish in the future.

Co-authorship network of co-authors of Mark C. Walters

This figure shows the co-authorship network connecting the top 25 collaborators of Mark C. Walters. A scholar is included among the top collaborators of Mark C. Walters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark C. Walters. Mark C. Walters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Betibeglogene Autotemcel (Beti-cel) Gene Addition Therapy Results in Durable Hemoglobin A (HbA) Production with up to 10 Years of Follow-up in Participants with Transfusion-Dependent β-Thalassemia 2025 ·Transplantation and Cellular Therapy ·Timothy S. Olson, Alexis A. Thompson, Janet L. Kwiatkowski, Jennifer Schneiderman, Isabelle Thuret, Andreas E. Kulozik, Evangelia Yannaki, Marina Cavazzana, Suradej Hongeng, Martin G. Sauer, Adrian J. Thrasher, Ashutosh Lal, John E.J. Rasko, (unknown), Tao Ge, (unknown), (unknown), Mark C. Walters, Franco Locatelli	0
2	Nonclinical evaluation of renizgamglogene autogedtemcel for SCD and TDT 2025 ·Molecular Therapy ·Eugenio Marco, Patricia Sousa, (unknown), (unknown), Jack Heath, Ramya Viswanathan, John A. Zuris, Gregory Gotta, Georgia Giannoukos, Scott D. Hansen, David K. Wood, Mark C. Walters, John F. Tisdale, Christopher J. Wilson, Kai‐Hsin Chang	0
3	Incremental eligibility criteria for the BMT CTN 1507 haploidentical trial for children with sickle cell disease 2024 ·Blood Advances ·(unknown), Mark C. Walters, Hemalatha G. Rangarajan, (unknown), Christopher McKinney, Catherine M. Bollard, Ghada Abusin, Mary Eapen, Adetola A. Kassim, Michael R. DeBaun	1
4	An Update on Lovotibeglogene Autotemcel (Lovo-cel) Clinical Trials for Sickle Cell Disease (SCD) and Analysis of Early Predictors of Response to Lovo-Cel 2024 ·Blood ·(unknown), Julie Kanter, Melissa A. Kinney, Janet L. Kwiatkowski, Robert Sheppard Nickel, Mark C. Walters, Suhag Parikh, Alexis A. Thompson, Anil George, Markus Y. Mapara, Paul L. Martin, Anjulika Chawla, (unknown), Lin Pan, Emily Sheldon‐Waniga, Francis J. Pierciey, John F. Tisdale, Ashish O. Gupta	3
5	Neurocognitive outcome in children with sickle cell disease after myeloimmunoablative conditioning and haploidentical hematopoietic stem cell transplantation: a non-randomized clinical trial 2024 ·Frontiers in Neurology ·Suzanne Braniecki, Elliott Vichinsky, Mark C. Walters, Shalini Shenoy, Qiuhu Shi, Theodore B. Moore, Julie‐An Talano, Susan K. Parsons, Allyson Flower, (unknown), (unknown), Erin Morris, (unknown), (unknown), Robert C. McKinstry, Christine Duncan, Carmella van de Ven, Mitchell S. Cairo	0
6	Updated Results of a Phase 1/2 Clinical Study of Zinc Finger Nuclease-Mediated Editing of BCL11A in Autologous Hematopoietic Stem Cells for Transfusion-Dependent Beta Thalassemia 2021 ·Blood ·Mark C. Walters, Angela R. Smith, Gary J. Schiller, Erica B. Esrick, David A. Williams, (unknown), Didier Rouy, (unknown), Gregory M. Vercellotti	15
7	Safety and Efficacy Outcomes in Pediatric Patients with Transfusion-Dependent β-Thalassemia (TDT) Receiving Betibeglogene Autotemcel (beti-cel; LentiGlobin for β-thalassemia) Gene Therapy in the Phase 3 Hgb-207 (Northstar-2) and Hgb-212 (Northstar-3) Studies 2021 ·Transplantation and Cellular Therapy ·Mark C. Walters, Janet L. Kwiatkowski, John B. Porter, Suradej Hongeng, Evangelia Yannaki, Andreas E. Kulozik, Martin G. Sauer, Adrian J. Thrasher, Isabelle Thuret, Ashutosh Lal, Ruiting Guo, Weijian Liu, Richard A. Colvin, Franco Locatelli, Alexis A. Thompson	1
8	Resolution of Serious Vaso-Occlusive Pain Crises: Results from the Ongoing Phase 1/2 HGB-206 Group C Study of LentiGlobin for Sickle Cell Disease (SCD; bb1111) Gene Therapy 2021 ·Transplantation and Cellular Therapy ·Mark C. Walters, Alexis A. Thompson, Markus Y. Mapara, Janet L. Kwiatkowski, Lakshmanan Krishnamurti, Banu Aygün, Kimberly A. Kasow, (unknown), Manfred Schmidt, (unknown), Francis J. Pierciey, (unknown), Ren Chen, Sunita Goyal, Julie Kanter, John F. Tisdale	1
9	Efficacy and Safety of Betibeglogene Autotemcel (beti-cel; LentiGlobin for β-thalassemia) Gene Therapy in 60 Patients with Transfusion-Dependent β-Thalassemia (TDT) Followed for up to 6 Years Post-Infusion 2021 ·Transplantation and Cellular Therapy ·Suradej Hongeng, Alexis A. Thompson, Janet L. Kwiatkowski, Franco Locatelli, John B. Porter, John E.J. Rasko, Marina Cavazzana, Martin G. Sauer, Adrian J. Thrasher, Isabelle Thuret, Ashutosh Lal, Andreas E. Kulozik, Evangelia Yannaki, Manfred Schmidt, (unknown), Ruiting Guo, Weijian Liu, Richard A. Colvin, Mark C. Walters	1
10	High-Level Correction of the Sickle Mutation is Amplified in Vivo During Erythroid Differentiation 2021 ·SSRN Electronic Journal ·Wendy Magis, Mark A. DeWitt, Stacia K. Wyman, Jonathan T. Vu, Seok‐Jin Heo, Shirley Shao, (unknown), Zulema Romero, Beatriz Campo Fernandez, Suzanne Saïd, Matthew McNeill, Garrett R. Rettig, Yongming Sun, Yu Wang, Mark A. Behlke, (unknown), Dario Boffelli, Mark C. Walters, Jacob E. Corn, David I. K. Martin	1
11	Restoring Iron Homeostasis in Pts Who Achieved Transfusion Independence after Treatment with Betibeglogene Autotemcel Gene Therapy: Results from up to 7 Years of Follow-up 2021 ·Blood ·Alexis A. Thompson, Franco Locatelli, Evangelia Yannaki, Mark C. Walters, John B. Porter, Suradej Hongeng, Andreas E. Kulozik, Martin G. Sauer, Adrian J. Thrasher, Isabelle Thuret, Ashutosh Lal, Marina Cavazzana, (unknown), Lin Du, Richard A. Colvin, Janet L. Kwiatkowski	2
12	Favorable Outcomes in Pediatric Patients in the Phase 3 Hgb-207 (Northstar-2) and Hgb-212 (Northstar-3) Studies of Betibeglogene Autotemcel Gene Therapy for the Treatment of Transfusion-Dependent β-Thalassemia 2020 ·Blood ·Alexis A. Thompson, Janet L. Kwiatkowski, John B. Porter, Suradej Hongeng, Evangelia Yannaki, Andreas E. Kulozik, Martin G. Sauer, Adrian J. Thrasher, Isabelle Thuret, Ashutosh Lal, Ruiting Guo, Weijian Liu, Richard A. Colvin, Mark C. Walters, Franco Locatelli	7
13	Long-Term Efficacy and Safety of Betibeglogene Autotemcel Gene Therapy for the Treatment of Transfusion-Dependent β-Thalassemia: Results in Patients with up to 6 Years of Follow-up 2020 ·Blood ·Janet L. Kwiatkowski, Mark C. Walters, Suradej Hongeng, Franco Locatelli, (unknown), Marina Cavazzana, Ying Chen, Richard A. Colvin, Alexis A. Thompson	8
14	Resolution of Serious Vaso-Occlusive Pain Crises and Reduction in Patient-Reported Pain Intensity: Results from the Ongoing Phase 1/2 HGB-206 Group C Study of LentiGlobin for Sickle Cell Disease (bb1111) Gene Therapy 2020 ·Blood ·Alexis A. Thompson, Mark C. Walters, Markus Y. Mapara, Janet L. Kwiatkowski, Lakshmanan Krishnamurti, Banu Aygün, Kimberly A. Kasow, (unknown), Manfred Schmidt, (unknown), Francis J. Pierciey, (unknown), (unknown), Ren Chen, Sunita Goyal, Julie Kanter, John F. Tisdale	9
15	Next Generation Sequence Minimal Residual Disease (NGS-MRD) Predicts Outstanding Event Free Survival (EFS) Regardless of Hematopoietic Cell Transplantation (HCT) Preparative Approach or Graft Alpha/Beta Depletion in Children with Acute Lymphoblastic Leukemia (ALL) 2019 ·Blood ·Hisham Abdel‐Azim, Christopher C. Dvorak, Nancy Bunin, Mark C. Walters, Julie‐An Talano, Eric Anderson, Jemily Malvar, (unknown), Sonali Chaudhury, Mitchell S. Cairo, Carrie L. Kitko, Allison P. Jacob, Dimitri Monos, (unknown), Michael A. Pulsipher	0
16	Related and Unrelated Donor Transplantation for β Thalassemia Major: Results of an International Survey 2018 ·Blood ·Chunfu Li, Vikram Mathews, Biju George, Soyoung Kim, Kyle Hebert, Hua Jiang, Changgang Li, Yiping Zhu, Daniel A. Keesler, Rajni Agarwal, Jaap Jan Boelens, Christopher C. Dvorak, Jeffery J. Auletta, Rakesh K. Goyal, (unknown), Kimberly A. Kasow, David M. Margolis, Shalini Shenoy, Mark C. Walters, Mary Eapen	1
17	Familial Haploidentical (FHI) T-Cell Depleted (TCD) with T-Cell Addback Stem Cell Transplantation for Patients with High-Risk Sickle Cell Disease (SCD) (IND 14359) 2017 ·Biology of Blood and Marrow Transplantation ·Julie‐An Talano, (unknown), Carolyn A. Keever-Taylor, Mark C. Walters, Shalini Shenoy, Theodore B. Moore, Susan K. Parsons, Allen J. Dozor, Deborah Friedman, Qiuhu Shi, Suzanne Braniecki, Brenda J. Grossman, Rona Singer Weinberg, Erin Morris, (unknown), (unknown), Janet Ayello, (unknown), Lee Ann Baxter‐Lowe, Mitchell S. Cairo	1
18	Umbilical Cord Blood Transplantation for Children with Thalassemia and Sickle Cell Disease 2011 ·Biology of Blood and Marrow Transplantation ·Annalisa Ruggeri, Mary Eapen, (unknown), Mitchell S. Cairo, Monica Bhatia, Joanne Kurtzberg, John R. Wingard, Anders Fasth, Luca Lo Nigro, Mouhab Ayas, Duncan Purtill, Karim Boudjedir, (unknown), Mark C. Walters, John E. Wagner, Éliane Gluckman, Vanderson Rocha	143
19	Stem Cell Transplantation with S‐59 Photochemically Treated T‐Cell Add‐Backs to Establish Allochimerism in Murine Thalassemia 2005 ·Annals of the New York Academy of Sciences ·Frans A. Kuypers, Gordon A. Watson, (unknown), Mark C. Walters, J. L. Hamrick, John E. Hearst	3
20	Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin 2004 ·Bone Marrow Transplantation ·John Horan, Jane L. Liesveld, Paul F. Fenton, Neil Blumberg, Mark C. Walters	94

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact